After searching the literature, we found neither a case of ovarian cancer-related osteomalacia nor detailed phosphate and FGF23 data of patients with ovarian cancer to draw a figure comparing serum phosphate and FGF23 levels purely in patients with ovarian cancer. This evidence concerns the gene FGF23 and ovarian carcinoma.